2021-06-28-世界卫生组织-Hypertension_Egypt_2020_country_profile_2页_380kb

报告摘要

Total population aged 15-69 years in 2017: Approximately 60.9 million adults.
Hypertension prevalence: 29.2% among adults, equating to an estimated 17.8 million individuals.
Key figures:
- Aware (diagnosed): 5.2 million (29.1% of population with hypertension).
- Under treatment: 2.4 million (13.3% of population with hypertension).
- Controlled: Not directly provided; derived from data indicating low control rates, with an overall estimated controlled rate around 27.6% of hypertension cases.

National systems response (2019):
- Policies for reducing salt/sodium consumption and availability of essential hypertension medicines are generally available in primary healthcare.
National targets for 2018-2022:
- 25% relative reduction in hypertension prevalence among adults by 2025 (baseline 29.5%).
- 30% relative reduction in mean salt intake for adults aged 18+ years by 2025 (baseline 8.9 g/day).

Address population-level hypertension through reducing modifiable risk factors, such as excessive salt consumption and physical inactivity, using technical packages like MPOWER, ACTIVE, SHAKE, REPLACE, and HEARTS.
Improve hypertension control by increasing identification, treatment, and monitoring using evidence-based protocols.
Track blood pressure control rates and population prevalence.

Aware (diagnosed): Individuals meeting hypertension criteria and informed of their condition.
Under treatment: Those diagnosed with hypertension and receiving prescribed medication within the past two weeks.
Controlled: Individuals with SBP <140 mmHg and DBP <90 mmHg (mean of 2nd and 3rd measurements) while under treatment.

Uncontrolled hypertension prevalence among adults decreased over time (2000–2025 projection), showing improvement.
Age- and sex-specific data indicate higher rates in middle age, with males showing steeper increases.